Stock listing
ALCLS Stock Price, News, Filings & Events — Cellectis S.a.
Selected listing: ALCLS · EURONEXT · EUR · FR
This page tracks Cellectis S.a.'s ALCLS:EURONEXT listing on EURONEXT in EUR for FR, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ALCLS:EURONEXT. ALCLS:EURONEXT is the stock-level entry point for investors researching Cellectis S.a., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Cellectis S.A. is a public biotechnology company based in France, trading under the ticker ALCLS. The company focuses on developing innovative gene-editing technologies for therapeutic applications. With a market capitalization of approximately €202.56 million, Cellectis aims to advance its research and development efforts in the field of genomics.
- Ticker
- ALCLS:EURONEXT
- Asset type
- Stock
- Market cap
- $261.3M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- EURONEXT
- Currency
- EUR
Cellectis S.a. ALCLS:EURONEXT stock context
This page tracks Cellectis S.a.'s ALCLS:EURONEXT listing on EURONEXT in EUR for FR, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ALCLS:EURONEXT. ALCLS:EURONEXT is the stock-level entry point for investors researching Cellectis S.a., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Cellectis S.A. is a public biotechnology company based in France, trading under the ticker ALCLS. The company focuses on developing innovative gene-editing technologies for therapeutic applications. With a market capitalization of approximately €202.56 million, Cellectis aims to advance its research and development efforts in the field of genomics.
Latest news from Cellectis S.a.
Cellectis to Report Second Quarter Financial Results on August 6, 2026
July 30, 2026
Cellectis Reports Results from Shareholders Meeting Held on June 25, 2026
June 25, 2026
Cellectis Presents Final Phase 1 Results of Lasme-cel and Preliminary Results on Eti-cel at EHA 2026 Congress
June 11, 2026
Cellectis Receives FDA RMAT Designation for lasme-cel, the First Allogeneic CAR-T Therapy in a Pivotal Trial for Patients with r/r B-ALL
June 9, 2026
Cellectis S A : Report of the Board of Directors - Combined General Meeting of Shareholders - June 25, 2026
May 29, 2026
Cellectis S.a. earnings calls
Cellectis Inc. (CLLS) Q1 2026 Earnings Call
May 11, 2026 · Replay with transcript and chapters
Cellectis Inc. (CLLS) Q4 2025 Earnings Call
March 20, 2026 · Replay with transcript and chapters
Cellectis Inc. (CLLS) Q2 2025 Earnings Call
August 5, 2025 · Replay with transcript and chapters
Cellectis Inc. (CLLS) Q4 2024 Earnings Call
March 14, 2025 · Replay with transcript and chapters
Cellectis Inc. (CLLS) Q1 2024 Earnings Call
May 29, 2024 · Replay with transcript and chapters
Cellectis Inc. (CLLS) Q3 2023 Earnings Call
November 7, 2023 · Replay with transcript and chapters
Research Cellectis S.a.
Cellectis S.a. investor report
Review AI stock analysis and investor report context for ALCLS:EURONEXT.
Cellectis S.a. company profile
View the public company page for Cellectis S.a. on 6ix.
Cellectis S.a. news
Read company news and market updates connected to Cellectis S.a..
Cellectis S.a. investor events
Find investor webinars, events, and replay context for Cellectis S.a..
Alternate listings
CLLS:NASDAQ
US · USD
Alternate listing for Cellectis S.a.; the primary context on this page is ALCLS:EURONEXT.
ZVA:GETTEX
DE · EUR
Alternate listing for Cellectis S.a.; the primary context on this page is ALCLS:EURONEXT.
A0MKPR:LSX
DE · EUR
Alternate listing for Cellectis S.a.; the primary context on this page is ALCLS:EURONEXT.
0WA2:LSIN
GB · EUR
Alternate listing for Cellectis S.a.; the primary context on this page is ALCLS:EURONEXT.
A0MKPR:LS
DE · EUR
Alternate listing for Cellectis S.a.; the primary context on this page is ALCLS:EURONEXT.
ZVA:TRADEGATE
DE · EUR
Alternate listing for Cellectis S.a.; the primary context on this page is ALCLS:EURONEXT.
CLLS:BOATS
US · USD
Alternate listing for Cellectis S.a.; the primary context on this page is ALCLS:EURONEXT.
ZVAA:GETTEX
DE · EUR
Alternate listing for Cellectis S.a.; the primary context on this page is ALCLS:EURONEXT.
A14QZE:LS
DE · EUR
Alternate listing for Cellectis S.a.; the primary context on this page is ALCLS:EURONEXT.
ZVA:MUN
DE · EUR
Alternate listing for Cellectis S.a.; the primary context on this page is ALCLS:EURONEXT.
ZVA:HAM
DE · EUR
Alternate listing for Cellectis S.a.; the primary context on this page is ALCLS:EURONEXT.
CMVLF:OTC
US · USD
Alternate listing for Cellectis S.a.; the primary context on this page is ALCLS:EURONEXT.